PT  - JOURNAL ARTICLE
AU  - Weiss, Shennan A
AU  - Fried, Itzhak
AU  - Engel, Jerome
AU  - Sperling, Michael R.
AU  - Wong, Robert K.S.
AU  - Nir, Yuval
AU  - Staba, Richard J
TI  - Fast ripples reflect increased excitability that primes epileptiform spikes
AID  - 10.1101/2023.03.26.23287702
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.26.23287702
4099  - http://medrxiv.org/content/early/2023/04/19/2023.03.26.23287702.short
4100  - http://medrxiv.org/content/early/2023/04/19/2023.03.26.23287702.full
AB  - The neuronal circuit disturbances that drive interictal and ictal epileptiform discharges remains elusive. Using a combination of extraoperative macro- and micro-electrode interictal recordings in six presurgical patients during non-rapid eye movement (REM) sleep we found that, exclusively in the seizure onset zone, fast ripples (FR; 200-600Hz), but not ripples (80-200 Hz), frequently occur <300 msec before an interictal intracranial EEG (iEEG) spike with a probability exceeding chance (bootstrapping, p<1e-5). Such FR events are associated with higher spectral power (p<1e-10) and correlated with more vigorous neuronal firing than solitary FR (generalized linear mixed-effects model, GLMM, p<1e-3) irrespective of FR power. During the iEEG spike that follows a FR, action potential firing is lower than during a iEEG spike alone (GLMM, p<1e-10), reflecting an inhibitory restraint of iEEG spike initiation. In contrast, ripples do not appear to prime epileptiform spikes. We next investigated the clinical significance of pre-spike FR in a separate cohort of 23 patients implanted with stereo EEG electrodes who underwent resections. In non-REM sleep recordings, sites containing a high proportion of FR preceding iEEG spikes correlate with brain areas where seizures begin more than solitary FR (p<1e-5). Despite this correlation, removal of these sites does not guarantee seizure freedom. These results are consistent with the hypothesis that FR preceding EEG spikes reflect an increase in local excitability that primes EEG spike discharges preferentially in the seizure onset zone and that epileptogenic brain regions are necessary, but not sufficient, for initiating interictal epileptiform discharges.Competing Interest StatementM.R.S has received compensation for speaking at continuing medical education (CME) programs from Medscape, Projects for Knowledge, International Medical Press, and Eisai. He has consulted for Medtronic, Neurelis, and Johnson & Johnson. He has received research support from Eisai, Medtronic, Neurelis, SK Life Science, Takeda, Xenon, Cerevel, UCB Pharma, Janssen, and Engage Pharmaceuticals. He has received royalties from Oxford University Press and Cambridge University Press. The remainder of the authors declare no competing interests. Funding StatementK23 NS094633 a Junior Investigator Award from the American Epilepsy Society R01 NS106958 R01 NS033310 European Research Council ERC-2019-CoG 864353 We would also like to thank Christina Louise George Trust and the Resnick Family Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of California Los Angeles Institutional Review Board Thomas Jefferson University Institutional Review BoardI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data and code to reproduce the results and figures are available at https://zenodo.org/record/7685943#.Y_5UHybML9Z and https://github.com/shenweiss/FRexcitabilityprespike. The raw data is available upon reasonable request. https://zenodo.org/record/7685943#.Y_5UHybML9Z